Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK11 | Q15759 | 1/20 | 0.36 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.36 |
| ▸ | ADRA1D | P25100 | 6/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 6/20 | 0.33 |
| ▸ | ADRA1B | P35368 | 6/20 | 0.33 |
| ▸ | ABL1 | P00519 | 1/20 | 0.33 |
| ▸ | SRC | P12931 | 1/20 | 0.33 |
| ▸ | CPT2 | P23786 | 2/20 | 0.32 |
| ▸ | CPT1A | P50416 | 2/20 | 0.32 |
| ▸ | CPT1B | Q92523 | 2/20 | 0.32 |
| ▸ | MAP3K7 | O43318 | 2/20 | 0.32 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7969564 | 0.93 | MAPK11 (0.37) | MAPK11MAPK14ADRA1DADRA1AADRA1B | |
| SCHEMBL7967019 | 0.87 | CPT1A (0.34) | ADRA1DADRA1AADRA1BCPT2CPT1A | |
| Hydrochloric Acid SCHEMBL7476852 | 0.84 | MAPK11 (0.36) | MAPK11MAPK14ADRA1DADRA1AADRA1B | |
| SCHEMBL7475346 | 0.83 | MAP3K7 (0.32) | ADRA1DADRA1AADRA1BABL1SRC | |
| SCHEMBL7474244 | 0.81 | AVPR2 (0.33) | ADRA1DADRA1AADRA1BMAP3K7 | |
| Hydrochloric Acid SCHEMBL7971911 | 0.80 | MAP3K7 (0.35) | ADRA1DADRA1AADRA1BMAP3K7 | |
| SCHEMBL7955154 | 0.80 | ADRA1D (0.32) | ADRA1DADRA1AADRA1BMAP3K7 | |
| SCHEMBL7478471 | 0.79 | MAP3K7 (0.36) | ADRA1DADRA1AADRA1BMAP3K7 | |
| Hydrochloric Acid SCHEMBL7954117 | 0.79 | MAP3K7 (0.33) | ADRA1DADRA1AADRA1BMAP3K7 | |
| SCHEMBL7972157 | 0.79 | MAP3K7 (0.32) | ADRA1DADRA1AADRA1BMAP3K7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6316482-B1 | FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2001-11-13 | — | — | US | disclosed |